| Dr Adeteju Ogunrinde, MD | |
|
605 Post Office Rd, Suite 102, Waldorf, MD 20602-1913 | |
| (301) 870-1789 | |
| (301) 374-2662 |
| Full Name | Dr Adeteju Ogunrinde |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 605 Post Office Rd, Waldorf, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083711733 | NPI | - | NPPES |
| 224416100 | Medicaid | MD | |
| 1548544992 | Other | MD | NATIONAL NPI -PRACTICE |
| 359185900 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | D47254 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adeteju Ogunrinde, MD 605 Post Office Rd, Suite 102, Waldorf, MD 20602-1913 Ph: (301) 870-1789 | Dr Adeteju Ogunrinde, MD 605 Post Office Rd, Suite 102, Waldorf, MD 20602-1913 Ph: (301) 870-1789 |
News Archive
Seattle Genetics, Inc. today reported data from a phase I weekly-dosing clinical trial of brentuximab vedotin (SGN-35), an antibody-drug conjugate (ADC), including multiple complete and partial remissions in patients with relapsed or refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma (ALCL).
An innovative model of dementia care that significantly reduces emergency department visits and hospitalizations, and encourages use of medications that are not harmful to older brains, has now been used to treat over 1,000 patients. The Aging Brain Care model was developed by researcher-clinicians from the Regenstrief Institute and the Indiana University School of Medicine.
The spread of SARS-CoV-2 is driven by the high proportion of asymptomatic and very mild infections, allowing people to move around and engage in public activity normally. There are many modeling studies that suggest that large-scale screening for the presence of this virus can help curb transmission at this point, from people with few or no symptoms. A new study points out the accuracy of SARS-CoV-2 antigen-detection rapid diagnostic tests for this purpose when used at the point-of-care.
A research team today announced the launch of a European large-scale clinical trial of Nilvadipine, an Alzheimer's disease drug developed at the Roskamp Institute in Sarasota.
Cell Therapeutics, Inc.today announced that the Gynecologic Oncology Group informed CTI that it has completed patient enrollment in the GOG-0212 Phase 3 clinical trial of investigational agent paclitaxel poliglumex as maintenance therapy in ovarian cancer.
› Verified 4 days ago
Dr. Pankaj Vaidya, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3600 Leonardtown Rd, Suite 101, Waldorf, MD 20601 Phone: 301-645-4320 Fax: 301-843-2384 | |
Om P Chhabra, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3600 Leonardtown Rd, Suite 101, Waldorf, MD 20601 Phone: 301-645-5951 Fax: 301-843-2384 | |
Alexandra Mountford, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3500 Old Washington Rd Ste 101, Waldorf, MD 20602 Phone: 301-885-5020 Fax: 240-419-5217 | |
Dr. Pedro Sarmiento Jr., M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 11885 Holly Lane, Suite 1, Waldorf, MD 20601 Phone: 301-932-5299 Fax: 301-645-9442 | |
Misha Capri Purnell, CPNP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3450 Old Washington Rd Ste 100, Waldorf, MD 20602 Phone: 301-572-3032 | |
Dr. Nikisha Holly Smith, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 11315 Pembrooke Sq, Suite 110, Waldorf, MD 20603 Phone: 301-645-6165 Fax: 301-843-7232 |